New data at ASH underscore the potential for durable, clinically important responses with momelotinib for myelofibrosis patientsBusiness Wire • 12/11/22
GSK and Sanofi shares surge after Florida ruling dismisses Zantac lawsuits in what one analyst describes as ‘best-case scenario'Market Watch • 12/07/22
Why GSK Plc And Sanofi SA Stock Are Shooting Higher - GSK (NYSE:GSK), Sanofi (NASDAQ:SNY)Benzinga • 12/06/22
GSK Phase 3 trial for Jemperli endometrial cancer treatment met primary endpointMarket Watch • 12/02/22